Results 211 to 220 of about 24,939 (257)
Current progress of 1,2,3-triazole hybrids as EGFR inhibitors for cancer therapy - a literature review. [PDF]
Khasawneh HEN +11 more
europepmc +1 more source
Synthesis of new DFNS/ZnTiO<sub>3</sub> nanoparticles as a nanocatalyst for the reaction of quinazoline-2, 4(1H, 3H)-dione with CO<sub>2</sub>. [PDF]
Amarloo F +3 more
europepmc +1 more source
Pyrimidine-containing natural products: occurrences and biological activities. [PDF]
Yao JN, Zhu Y, Chen HP, Chen Y.
europepmc +1 more source
PDE1B and PDE10A as novel targets for schizophrenia: from molecular design and synthesis to therapeutic promise. [PDF]
Rautela J +6 more
europepmc +1 more source
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF QUINAZOLINES AS ANTICONVULSANT AGENTS
SWAPNA BATTALA +4 more
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Quinazolines. Part XV. Hexahydro- and octahydro-quinazolines
Journal of the Chemical Society C: Organic, 19713,4,5,6,7,8-Hexahydroquinazoline, obtained by catalytic reduction of 5,6,7,8-tetrahydroquinazoline, was slowly oxidised by air to the starting material in chloroform solution, but in aqueous alkali it was degraded to 2-formamidomethylcyclohexanone. trans-4a,5,6,7,8,8a-Hexahydroquinazolin-4(1 - or 3-H)-one was shown to be a tautomeric mixture of the (1H)
W. L. F. Armarego, Toshihiko Kobayashi
openaire +1 more source
Dermatitis from quinazoline oxide
Contact Dermatitis, 1986Dermatitis from 2‐chloromethyl‐4‐phenyl‐6‐chloroquinazoline‐3‐oxide, an intermediate product in the preparation of chlorodiazepoxide, is described in 29 workers at a pharmaceutical plant. All were patch test positive to quinazoline oxide (1%) and six to 0.05%. In most patients, the face was earlier and more severely involved than the hands.
P, Rebandel, E, Rudzki
openaire +2 more sources
ChemInform, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
N. N. Tonkikh +2 more
openaire +1 more source
AbstractFor Abstract see ChemInform Abstract in Full Text.
N. N. Tonkikh +2 more
openaire +1 more source

